Cargando…
Novel Plasmodium falciparum metabolic network reconstruction identifies shifts associated with clinical antimalarial resistance
BACKGROUND: Malaria remains a major public health burden and resistance has emerged to every antimalarial on the market, including the frontline drug, artemisinin. Our limited understanding of Plasmodium biology hinders the elucidation of resistance mechanisms. In this regard, systems biology approa...
Autores principales: | Carey, Maureen A., Papin, Jason A., Guler, Jennifer L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5518114/ https://www.ncbi.nlm.nih.gov/pubmed/28724354 http://dx.doi.org/10.1186/s12864-017-3905-1 |
Ejemplares similares
-
Extrachromosomal DNA amplicons in antimalarial‐resistant Plasmodium falciparum
por: McDaniels, Jennifer M., et al.
Publicado: (2020) -
The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC
por: Verity, Robert, et al.
Publicado: (2020) -
Antimalarial drug targets in Plasmodium falciparum predicted by stage-specific metabolic network analysis
por: Huthmacher, Carola, et al.
Publicado: (2010) -
Robenidine Analogues Are Potent Antimalarials in Drug-Resistant
Plasmodium falciparum
por: Krollenbrock, Alina, et al.
Publicado: (2021) -
Comparison of the susceptibility of Plasmodium knowlesi and Plasmodium falciparum to antimalarial agents
por: van Schalkwyk, Donelly A, et al.
Publicado: (2017)